Modulation of chemokine production in lung microvascular endothelial cells by dopamine is mediated via an oxidative mechanism

被引:28
作者
Beck, GC
Oberacker, R
Kapper, S
von Zabern, D
Schulte, J
van Ackern, K
van der Woude, FJ
Yard, BA
机构
[1] Univ Mannheim, Inst Anaesthesiol, D-68167 Mannheim, Germany
[2] Univ Mannheim, Med Clin 5, D-68167 Mannheim, Germany
关键词
D O I
10.1165/ajrcmb.25.5.4544
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum concentrations of catecholamines are high in patients with sepsis or acute respiratory distress syndrome (ARDS). Because chemokines mediate the recruitment of neutrophils into inflammatory sites, we addressed the question of whether dopamine (DA) is able to influence chemokine production in endothelial cells under basal and proinflammatory conditions. To this end, lung microvascular endothelial cells (LMVEC) were stimulated or not for 24 h with the bacterial toxins lipopolysaccharide (LPS) (1 mug/ml) or lipoteichonic acid (LTA) (10 mug/ml) in the presence or absence of various concentrations of DA (1-100 mug/ml). Whereas under basal and stimulatory conditions, the addition of DA to endothelial cells dose-dependently increased IL-8 production, the production of ENA-78 and Gro-alpha was significantly inhibited (P < 0.01). This effect could still be demonstrated when the cells were stimulated for up to 3 h with LPS before DA administration. Similar findings were detected for the mRNA expression of these chemokines. The influence of DA on chemokine production was not receptor mediated and could be prevented by antioxidants or radical scavengers. Moreover, addition of H2O2 to endothelial cells gave results similar to those observed with DA stimulation, suggesting a pivotal role for reactive oxygen species in DA-mediated modulation of chemokine production in endothelial cells. Our data thus demonstrate that DA administration results in the induction of oxidative stress, with profound effects on endothelial chemokine production.
引用
收藏
页码:636 / 643
页数:8
相关论文
共 48 条
  • [11] Nuclear factor κB:: a pivotal role in the systemic inflammatory response syndrome and new target for therapy
    Christman, JW
    Lancaster, LH
    Blackwell, TS
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (11) : 1131 - 1138
  • [12] The role of nuclear factor-κ B in pulmonary diseases
    Christman, JW
    Sadikot, RT
    Blackwell, TS
    [J]. CHEST, 2000, 117 (05) : 1482 - 1487
  • [13] Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity
    Cook, JA
    Wink, DA
    Blount, V
    Krishna, MC
    Hanbauer, I
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1996, 28 (5-6) : 609 - 617
  • [14] PHARMACOKINETICS OF DOPAMINE IN INFANTS AND CHILDREN
    ELDADAH, MK
    SCHWARTZ, PH
    HARRISON, R
    NEWTH, CJL
    [J]. CRITICAL CARE MEDICINE, 1991, 19 (08) : 1008 - 1011
  • [15] Inotropes inhibit endothelial cell surface adhesion molecules induced by interleukin-1 beta
    Fortenberry, JD
    Huber, AR
    Owens, ML
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (02) : 303 - 308
  • [16] Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis
    Gabbay, M
    Tauber, M
    Porat, S
    Simantov, R
    [J]. NEUROPHARMACOLOGY, 1996, 35 (05) : 571 - 578
  • [17] Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells
    Gornikiewicz, A
    Sautner, T
    Brostjan, C
    Schmierer, B
    Függer, R
    Roth, E
    Mühlbacher, F
    Bergmann, M
    [J]. FASEB JOURNAL, 2000, 14 (09) : 1093 - 1100
  • [18] GRAHAM DG, 1978, MOL PHARMACOL, V14, P633
  • [19] SUSTAINED ELEVATION IN CIRCULATING CATECHOLAMINE LEVELS DURING POLYMICROBIAL SEPSIS
    HAHN, PY
    WANG, P
    TAIT, SM
    BA, ZF
    REICH, SS
    CHAUDRY, IH
    [J]. SHOCK, 1995, 4 (04): : 269 - 273
  • [20] REACTIVE OXYGEN SPECIES AND THE CENTRAL-NERVOUS-SYSTEM
    HALLIWELL, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 59 (05) : 1609 - 1623